17-ketosteroids and Arrhythmias--Cardiac

ST-segment elevation following temporary coronary artery occlusion was measured from nine epicardial leads in open-chest anaesthetized dogs. This was greatly reduced by the prior administration of the anti-dysrhythmic aminosteroid, ORG 6001. It is suggested that this effect is related either to a reduction in the extent and degree of myocardial ischaemia or to prevention of K+ egress from ischaemic cells.

Topics: 17-Ketosteroids; Androstanes; Androstanols; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Vessels; Dogs; Female; Hemodynamics; Male

Org 6001 (3alpha-amino-5alpha-androstan-2beta-ol-17-one-hydrochloride) is an orally non-hormonal aminosteroid possessing antiarrhythmic activity. In 13 dogs the efficacy of the drug against ouabain-induced ventricular tachycardia (VT) was studied. VT was produced by a mean dose of 67.5 +/- 18.7 mug/kg ouabain, administered by continuous infusion of 25 mug/min. 20 min after the onset of VT an 0.125 mg/kg/min infusion of Org 6001 was initiated, doubling the dose every 10 min. In all dogs VT was reverted into normal sinus rhythm (NSR) by a dose of 9.72 +/- 7.07 mg/kg (0.87-20.75 mg/kg) Org 6001. The duration of VT ranged from 27-61 min (mean 47.1 +/- 11.4 min), including the 20 min waiting period. NSR persisted in 8 dogs until the experiment was terminated (90 min after onset of VT), while in 5 dogs VT returned after 3-23 min sufficient to revert VT into NSR. A bolus injection of Org 6001 (10 mg/kg) gave an immediate return to NSR in 3 dogs, in which VT was provoked again by administration of a second dose of ouabain after the 90 min period had elapsed. Though the interaction of ouabain makes a quantitative analysis of the negative inotropic effects difficult, it appeared that there uas no major hemodynamic deterioration during and after treatment with Org 6001. During digitalization there was a significant increase in the first derivative of left ventricular systolic pressure (peak LVdP/dt) from 2340 +/- 600 to 3650 +/- 1070 mm Hg/sec and in peripheral resistance, while heart rate decreased. During VT, left ventricular systolic pressure (LVSP) and mean aortic pressure (MAP) dropped by approximately 20 mm Hg, while heart rate increased significantly. After treatment with Org 6001, LVSP and MAP further decreased to 128 +/- 30 mm Hg (p less than 0.05) areased to 128 +/- 30 mm Hg (p less than 0.05) and 112 +/- 20 mm Hg respectively. Peak LVdP/dt fell from 3650 +/- 1390 to 2780 +/- 970 mm Hg/sec (p less than 0.05). Heart rate had dropped to 126 +/- 22 beats/min (p less than 0.05). During the first 30 min after Org 6001 infusion was stopped none of the parameters showed significant changes, although peak LVdP/dt rose slightly. It is shown in the present investigation that Org 6001 has effective antiarrhythmic properties in controlling ouabain-induced VT with acceptable cardiodepressant actions.

Topics: 17-Ketosteroids; Androstanes; Androstanols; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Output; Depression, Chemical; Dogs; Electrocardiography; Heart Rate; Heart Ventricles; Hemodynamics; Ouabain; Tachycardia; Time Factors

Topics: 17-Ketosteroids; Aconitine; Androstanes; Androstanols; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Coronary Vessels; Dogs; Heart Rate; Hydroxysteroids; Lidocaine; Ligation; Male; Myocardial Contraction; Ouabain; Rats

Topics: 17-Ketosteroids; Aged; Arrhythmias, Cardiac; Asthenia; Blood Pressure; Blood Volume; Chlorides; Creatine; Dehydration; Dysautonomia, Familial; Female; Fludrocortisone; Follow-Up Studies; Heart Diseases; Hemorrhage; Humans; Hyponatremia; Hypotension, Orthostatic; Kidney Diseases; Kidney Function Tests; Male; Nitrogen; Parkinson Disease; Potassium; Sex Factors; Sodium; Urinary Tract Infections; Water-Electrolyte Balance

Topics: 17-Ketosteroids; Adolescent; Adrenal Cortex Hormones; Anemia; Arrhythmias, Cardiac; Body Temperature; Bradycardia; Carbohydrate Metabolism; Cardiomegaly; China; Electrocardiography; Geriatrics; Hair; Humans; Hyperkalemia; Hyponatremia; Hypopituitarism; Pigmentation; Thyroid Function Tests